You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 280 No. 23, December 16, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Journalology/ Peer Review/ Authorship
 •Humanities
 •Medicine and the Media
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reporting of Public Health Hazards or Major Advances—Revision of Uniform Requirements

Richard M. Glass, MD

JAMA. 1998;280:2035.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Most medical journals do not wish to publish work that has already been released or published in print or electronic media. The Uniform Requirements for Manuscripts Submitted to Biomedical Journals1 (URM) of the International Committee of Medical Journal Editors (ICMJE) already indicate that such policies should not preclude consideration of a complete report following publication of an abstract or a presentation at a professional meeting, even if such presentations are covered in the media. However, authors are sometimes concerned whether reporting a public health hazard or major therapeutic advance directly to public media or governmental agencies will jeopardize subsequent medical journal publication of an article or letter to the editor dealing with the same topic.

Since 1994, the JAMA "Instructions for Authors" have stated, "Authors submitting manuscripts or letters to the editor regarding adverse drug or medical device reactions, reportable diseases, and the like should also . . . [Full Text of this Article]

Dr Glass is Deputy Editor, JAMA.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.